Canada’s marijuana growers’ stocks traded in the U.S. markets are growing as they stabilize from a harsh correction. However, in the long run, the pot sector is likely to be affected by the U.S. internal political issues that will hurt the market across the board as well.
The U.S. is now seeing the longest government shutdown on record, with a great number of employees at the country’s key agencies not working since December 22, 2018, which is detrimental to the U.S. national economy and its overall stock market overall.
Contrastingly, Tilray (TLRY) stock grew appreciably, as Privateer Holdings that owns the majority of Tilray's outstanding shares, announced it had no plans to “register, sell or distribute” its holdings “during the first half of 2019”. Given that the stock surged higher and kept on going and going above its IPO price, but then finally were back under $100, and with the upcoming IPO lock-up expiration, investors previously feared that some of the cannabis grower’s stock holders might want to sell it.
Aphria (OTC:APHA) stock was hurt by the news that its CEO Vic Neufeld and co-founder Cole Cacciavillani will part ways with the company “over the coming months”, which was counterbalanced by the business’ strong figures as its earnings soared by more than 60%.
Meanwhile, Aurora Cannabis (OTC:ACB) was bolstered up as its sales were predicted to grow.
Financial scouts anticipate that, in the offing, Canopy Growth (СGС) and Tilray are likely to jump to $40-$41 and $98-$100, while Aurora Cannabis Inc (OTC:ACB), Aphria Inc. and Cronos Group (СRON) are soon to be priced at $7-$7.5, $7.5-$8, and $14-$15, respectively.
Ivan Marchena, Libertex Analyst